Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]Code Context
trigger_error($message, E_USER_DEPRECATED);
}
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.' $stackFrame = (int) 1 $trace = [ (int) 0 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php', 'line' => (int) 2421, 'function' => 'deprecationWarning', 'args' => [ (int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.' ] ], (int) 1 => [ 'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php', 'line' => (int) 73, 'function' => 'offsetGet', 'class' => 'Cake\Http\ServerRequest', 'object' => object(Cake\Http\ServerRequest) {}, 'type' => '->', 'args' => [ (int) 0 => 'catslug' ] ], (int) 2 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php', 'line' => (int) 610, 'function' => 'printArticle', 'class' => 'App\Controller\ArtileDetailController', 'object' => object(App\Controller\ArtileDetailController) {}, 'type' => '->', 'args' => [] ], (int) 3 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php', 'line' => (int) 120, 'function' => 'invokeAction', 'class' => 'Cake\Controller\Controller', 'object' => object(App\Controller\ArtileDetailController) {}, 'type' => '->', 'args' => [] ], (int) 4 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php', 'line' => (int) 94, 'function' => '_invoke', 'class' => 'Cake\Http\ActionDispatcher', 'object' => object(Cake\Http\ActionDispatcher) {}, 'type' => '->', 'args' => [ (int) 0 => object(App\Controller\ArtileDetailController) {} ] ], (int) 5 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php', 'line' => (int) 235, 'function' => 'dispatch', 'class' => 'Cake\Http\ActionDispatcher', 'object' => object(Cake\Http\ActionDispatcher) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 6 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Http\BaseApplication', 'object' => object(App\Application) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 7 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php', 'line' => (int) 162, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 8 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Routing\Middleware\RoutingMiddleware', 'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 9 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php', 'line' => (int) 88, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 10 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Routing\Middleware\AssetMiddleware', 'object' => object(Cake\Routing\Middleware\AssetMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 11 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php', 'line' => (int) 96, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 12 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware', 'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 13 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 51, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 14 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php', 'line' => (int) 98, 'function' => 'run', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\MiddlewareQueue) {}, (int) 1 => object(Cake\Http\ServerRequest) {}, (int) 2 => object(Cake\Http\Response) {} ] ], (int) 15 => [ 'file' => '/home/brlfuser/public_html/webroot/index.php', 'line' => (int) 39, 'function' => 'run', 'class' => 'Cake\Http\Server', 'object' => object(Cake\Http\Server) {}, 'type' => '->', 'args' => [] ] ] $frame = [ 'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php', 'line' => (int) 73, 'function' => 'offsetGet', 'class' => 'Cake\Http\ServerRequest', 'object' => object(Cake\Http\ServerRequest) { trustProxy => false [protected] params => [ [maximum depth reached] ] [protected] data => [[maximum depth reached]] [protected] query => [[maximum depth reached]] [protected] cookies => [ [maximum depth reached] ] [protected] _environment => [ [maximum depth reached] ] [protected] url => 'latest-news-updates/health-ministry-to-import-1-5-million-doses-of-h1n1-vaccine-by-radhieka-pandeya-898/print' [protected] base => '' [protected] webroot => '/' [protected] here => '/latest-news-updates/health-ministry-to-import-1-5-million-doses-of-h1n1-vaccine-by-radhieka-pandeya-898/print' [protected] trustedProxies => [[maximum depth reached]] [protected] _input => null [protected] _detectors => [ [maximum depth reached] ] [protected] _detectorCache => [ [maximum depth reached] ] [protected] stream => object(Zend\Diactoros\PhpInputStream) {} [protected] uri => object(Zend\Diactoros\Uri) {} [protected] session => object(Cake\Http\Session) {} [protected] attributes => [[maximum depth reached]] [protected] emulatedAttributes => [ [maximum depth reached] ] [protected] uploadedFiles => [[maximum depth reached]] [protected] protocol => null [protected] requestTarget => null [private] deprecatedProperties => [ [maximum depth reached] ] }, 'type' => '->', 'args' => [ (int) 0 => 'catslug' ] ]deprecationWarning - CORE/src/Core/functions.php, line 311 Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421 App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 73 Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51 Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98
Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]Code Context
trigger_error($message, E_USER_DEPRECATED);
}
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.' $stackFrame = (int) 1 $trace = [ (int) 0 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php', 'line' => (int) 2421, 'function' => 'deprecationWarning', 'args' => [ (int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.' ] ], (int) 1 => [ 'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php', 'line' => (int) 74, 'function' => 'offsetGet', 'class' => 'Cake\Http\ServerRequest', 'object' => object(Cake\Http\ServerRequest) {}, 'type' => '->', 'args' => [ (int) 0 => 'artileslug' ] ], (int) 2 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php', 'line' => (int) 610, 'function' => 'printArticle', 'class' => 'App\Controller\ArtileDetailController', 'object' => object(App\Controller\ArtileDetailController) {}, 'type' => '->', 'args' => [] ], (int) 3 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php', 'line' => (int) 120, 'function' => 'invokeAction', 'class' => 'Cake\Controller\Controller', 'object' => object(App\Controller\ArtileDetailController) {}, 'type' => '->', 'args' => [] ], (int) 4 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php', 'line' => (int) 94, 'function' => '_invoke', 'class' => 'Cake\Http\ActionDispatcher', 'object' => object(Cake\Http\ActionDispatcher) {}, 'type' => '->', 'args' => [ (int) 0 => object(App\Controller\ArtileDetailController) {} ] ], (int) 5 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php', 'line' => (int) 235, 'function' => 'dispatch', 'class' => 'Cake\Http\ActionDispatcher', 'object' => object(Cake\Http\ActionDispatcher) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 6 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Http\BaseApplication', 'object' => object(App\Application) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 7 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php', 'line' => (int) 162, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 8 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Routing\Middleware\RoutingMiddleware', 'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 9 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php', 'line' => (int) 88, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 10 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Routing\Middleware\AssetMiddleware', 'object' => object(Cake\Routing\Middleware\AssetMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 11 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php', 'line' => (int) 96, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 12 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware', 'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 13 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 51, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 14 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php', 'line' => (int) 98, 'function' => 'run', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\MiddlewareQueue) {}, (int) 1 => object(Cake\Http\ServerRequest) {}, (int) 2 => object(Cake\Http\Response) {} ] ], (int) 15 => [ 'file' => '/home/brlfuser/public_html/webroot/index.php', 'line' => (int) 39, 'function' => 'run', 'class' => 'Cake\Http\Server', 'object' => object(Cake\Http\Server) {}, 'type' => '->', 'args' => [] ] ] $frame = [ 'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php', 'line' => (int) 74, 'function' => 'offsetGet', 'class' => 'Cake\Http\ServerRequest', 'object' => object(Cake\Http\ServerRequest) { trustProxy => false [protected] params => [ [maximum depth reached] ] [protected] data => [[maximum depth reached]] [protected] query => [[maximum depth reached]] [protected] cookies => [ [maximum depth reached] ] [protected] _environment => [ [maximum depth reached] ] [protected] url => 'latest-news-updates/health-ministry-to-import-1-5-million-doses-of-h1n1-vaccine-by-radhieka-pandeya-898/print' [protected] base => '' [protected] webroot => '/' [protected] here => '/latest-news-updates/health-ministry-to-import-1-5-million-doses-of-h1n1-vaccine-by-radhieka-pandeya-898/print' [protected] trustedProxies => [[maximum depth reached]] [protected] _input => null [protected] _detectors => [ [maximum depth reached] ] [protected] _detectorCache => [ [maximum depth reached] ] [protected] stream => object(Zend\Diactoros\PhpInputStream) {} [protected] uri => object(Zend\Diactoros\Uri) {} [protected] session => object(Cake\Http\Session) {} [protected] attributes => [[maximum depth reached]] [protected] emulatedAttributes => [ [maximum depth reached] ] [protected] uploadedFiles => [[maximum depth reached]] [protected] protocol => null [protected] requestTarget => null [private] deprecatedProperties => [ [maximum depth reached] ] }, 'type' => '->', 'args' => [ (int) 0 => 'artileslug' ] ]deprecationWarning - CORE/src/Core/functions.php, line 311 Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421 App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 74 Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51 Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98
Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]Code Contextif (Configure::read('debug')) {
trigger_error($message, E_USER_WARNING);
} else {
$response = object(Cake\Http\Response) { 'status' => (int) 200, 'contentType' => 'text/html', 'headers' => [ 'Content-Type' => [ [maximum depth reached] ] ], 'file' => null, 'fileRange' => [], 'cookies' => object(Cake\Http\Cookie\CookieCollection) {}, 'cacheDirectives' => [], 'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"> <html xmlns="http://www.w3.org/1999/xhtml"> <head> <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr680262adf319c-trace').style.display = (document.getElementById('cakeErr680262adf319c-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr680262adf319c-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr680262adf319c-code').style.display = (document.getElementById('cakeErr680262adf319c-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr680262adf319c-context').style.display = (document.getElementById('cakeErr680262adf319c-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr680262adf319c-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700"><</span><span style="color: #0000BB">head</span><span style="color: #007700">> </span></span></code> <span class="code-highlight"><code><span style="color: #000000"> <link rel="canonical" href="<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">); </span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">category</span><span style="color: #007700">-></span><span style="color: #0000BB">slug</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>/<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">seo_url</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>.html"/> </span></code></span> <code><span style="color: #000000"><span style="color: #0000BB"> </span><span style="color: #007700"><</span><span style="color: #0000BB">meta http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type" </span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html; charset=utf-8"</span><span style="color: #007700">/> </span></span></code></pre><pre id="cakeErr680262adf319c-context" class="cake-context" style="display: none;">$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp' $dataForView = [ 'article_current' => object(App\Model\Entity\Article) { 'id' => (int) 825, 'title' => 'Health ministry to import 1.5 million doses of H1N1 vaccine by Radhieka Pandeya', 'subheading' => '', 'description' => '<p align="justify"> <font face="arial,helvetica,sans-serif" size="3">The health ministry has placed an order to import 1.5 million doses of the swine flu vaccine into India, which will be available in January. </font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">This is contrary to the government&rsquo;s earlier claims of importing four million doses of the vaccine. Indian manufacturers will now supply the remaining doses. </font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">&ldquo;We have placed an order for importing 1.5 million doses already,&rdquo; said Vineet Chawdhry, joint secretary, health ministry. &ldquo;Indigenous production of the vaccine will be ready by March, so we will have that available soon as well.&rdquo;</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">The health ministry has been trying to make the vaccine available in India for the last two months and had sped up regulatory approvals for studies to be conducted on the safety of the vaccine. </font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">Chawdhry said India&rsquo;s Zydus Cadila would have the vaccine ready by March, so the government would not need to import batches, which is why an order for only 1.5 million doses has been placed at the moment.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">Cadila is not one of the three Indian drug makers being supported by the government to develop and manufacture the H1N1 flu vaccine. The ones that are supported are Serum Institute of India Ltd, Bharat Biotech International Ltd and Panacea Biotech Ltd. According to ministry officials, who declined to be named, vaccines of these three firms will not be ready before April.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">Chawdhry declined to name the overseas company that will supply the vaccine, citing a confidentiality clause. Ministry officials, however, have been in talks with four international vaccine makers&mdash;GlaxoSmithKline Plc (GSK), Baxter International Inc., Novartis AG and Sanofi Pasteur SA. </font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">On 1 December, Mint reported that the vaccines could be available in the country by the end of the month following approvals by the Indian regulator for human clinical trials to two multinational drug makers, GSK and Baxter, while among Indian vaccine makers, only Zydus Cadila had submitted the clinical trial protocol to the regulator to conduct trials of its vaccine candidate. </font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">The vaccine, said Chawdhry, would initially be made available to healthcare workers who come in direct contact with the virus and are at greater risk of being infected by it. It would could later be made available to the general public, either through government or private channels, he said.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">As on 29 December, India reported 25,572 confirmed cases of swine flu, of which 898 resulted in death. Delhi reported 8,306 cases, the highest among the states. </font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">According to World Health Organisation director general Margaret Chan, while the worst of the swine flu outbreak is over in the US and Canada, there is still intensive virus activity in some countries including India. Chan also warned that the virus could still mutate and countries must &ldquo;guard against complacency&rdquo;.<br /> </font> </p> ', 'credit_writer' => 'Live Mint, 30 December, 2009, http://www.livemint.com/2009/12/30204656/Health-ministry-to-import-15.html', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'health-ministry-to-import-1-5-million-doses-of-h1n1-vaccine-by-radhieka-pandeya-898', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 898, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [[maximum depth reached]], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ [maximum depth reached] ], '[dirty]' => [[maximum depth reached]], '[original]' => [[maximum depth reached]], '[virtual]' => [[maximum depth reached]], '[hasErrors]' => false, '[errors]' => [[maximum depth reached]], '[invalid]' => [[maximum depth reached]], '[repository]' => 'Articles' }, 'articleid' => (int) 825, 'metaTitle' => 'LATEST NEWS UPDATES | Health ministry to import 1.5 million doses of H1N1 vaccine by Radhieka Pandeya', 'metaKeywords' => null, 'metaDesc' => ' The health ministry has placed an order to import 1.5 million doses of the swine flu vaccine into India, which will be available in January. This is contrary to the government&rsquo;s earlier claims of importing four million doses of the...', 'disp' => '<p align="justify"><font >The health ministry has placed an order to import 1.5 million doses of the swine flu vaccine into India, which will be available in January. </font></p><p align="justify"><font >This is contrary to the government&rsquo;s earlier claims of importing four million doses of the vaccine. Indian manufacturers will now supply the remaining doses. </font></p><p align="justify"><font >&ldquo;We have placed an order for importing 1.5 million doses already,&rdquo; said Vineet Chawdhry, joint secretary, health ministry. &ldquo;Indigenous production of the vaccine will be ready by March, so we will have that available soon as well.&rdquo;</font></p><p align="justify"><font >The health ministry has been trying to make the vaccine available in India for the last two months and had sped up regulatory approvals for studies to be conducted on the safety of the vaccine. </font></p><p align="justify"><font >Chawdhry said India&rsquo;s Zydus Cadila would have the vaccine ready by March, so the government would not need to import batches, which is why an order for only 1.5 million doses has been placed at the moment.</font></p><p align="justify"><font >Cadila is not one of the three Indian drug makers being supported by the government to develop and manufacture the H1N1 flu vaccine. The ones that are supported are Serum Institute of India Ltd, Bharat Biotech International Ltd and Panacea Biotech Ltd. According to ministry officials, who declined to be named, vaccines of these three firms will not be ready before April.</font></p><p align="justify"><font >Chawdhry declined to name the overseas company that will supply the vaccine, citing a confidentiality clause. Ministry officials, however, have been in talks with four international vaccine makers&mdash;GlaxoSmithKline Plc (GSK), Baxter International Inc., Novartis AG and Sanofi Pasteur SA. </font></p><p align="justify"><font >On 1 December, Mint reported that the vaccines could be available in the country by the end of the month following approvals by the Indian regulator for human clinical trials to two multinational drug makers, GSK and Baxter, while among Indian vaccine makers, only Zydus Cadila had submitted the clinical trial protocol to the regulator to conduct trials of its vaccine candidate. </font></p><p align="justify"><font >The vaccine, said Chawdhry, would initially be made available to healthcare workers who come in direct contact with the virus and are at greater risk of being infected by it. It would could later be made available to the general public, either through government or private channels, he said.</font></p><p align="justify"><font >As on 29 December, India reported 25,572 confirmed cases of swine flu, of which 898 resulted in death. Delhi reported 8,306 cases, the highest among the states. </font></p><p align="justify"><font >According to World Health Organisation director general Margaret Chan, while the worst of the swine flu outbreak is over in the US and Canada, there is still intensive virus activity in some countries including India. Chan also warned that the virus could still mutate and countries must &ldquo;guard against complacency&rdquo;.<br /></font></p>', 'lang' => 'English', 'SITE_URL' => 'https://im4change.in/', 'site_title' => 'im4change', 'adminprix' => 'admin' ] $article_current = object(App\Model\Entity\Article) { 'id' => (int) 825, 'title' => 'Health ministry to import 1.5 million doses of H1N1 vaccine by Radhieka Pandeya', 'subheading' => '', 'description' => '<p align="justify"> <font face="arial,helvetica,sans-serif" size="3">The health ministry has placed an order to import 1.5 million doses of the swine flu vaccine into India, which will be available in January. </font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">This is contrary to the government&rsquo;s earlier claims of importing four million doses of the vaccine. Indian manufacturers will now supply the remaining doses. </font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">&ldquo;We have placed an order for importing 1.5 million doses already,&rdquo; said Vineet Chawdhry, joint secretary, health ministry. &ldquo;Indigenous production of the vaccine will be ready by March, so we will have that available soon as well.&rdquo;</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">The health ministry has been trying to make the vaccine available in India for the last two months and had sped up regulatory approvals for studies to be conducted on the safety of the vaccine. </font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">Chawdhry said India&rsquo;s Zydus Cadila would have the vaccine ready by March, so the government would not need to import batches, which is why an order for only 1.5 million doses has been placed at the moment.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">Cadila is not one of the three Indian drug makers being supported by the government to develop and manufacture the H1N1 flu vaccine. The ones that are supported are Serum Institute of India Ltd, Bharat Biotech International Ltd and Panacea Biotech Ltd. According to ministry officials, who declined to be named, vaccines of these three firms will not be ready before April.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">Chawdhry declined to name the overseas company that will supply the vaccine, citing a confidentiality clause. Ministry officials, however, have been in talks with four international vaccine makers&mdash;GlaxoSmithKline Plc (GSK), Baxter International Inc., Novartis AG and Sanofi Pasteur SA. </font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">On 1 December, Mint reported that the vaccines could be available in the country by the end of the month following approvals by the Indian regulator for human clinical trials to two multinational drug makers, GSK and Baxter, while among Indian vaccine makers, only Zydus Cadila had submitted the clinical trial protocol to the regulator to conduct trials of its vaccine candidate. </font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">The vaccine, said Chawdhry, would initially be made available to healthcare workers who come in direct contact with the virus and are at greater risk of being infected by it. It would could later be made available to the general public, either through government or private channels, he said.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">As on 29 December, India reported 25,572 confirmed cases of swine flu, of which 898 resulted in death. Delhi reported 8,306 cases, the highest among the states. </font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">According to World Health Organisation director general Margaret Chan, while the worst of the swine flu outbreak is over in the US and Canada, there is still intensive virus activity in some countries including India. Chan also warned that the virus could still mutate and countries must &ldquo;guard against complacency&rdquo;.<br /> </font> </p> ', 'credit_writer' => 'Live Mint, 30 December, 2009, http://www.livemint.com/2009/12/30204656/Health-ministry-to-import-15.html', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'health-ministry-to-import-1-5-million-doses-of-h1n1-vaccine-by-radhieka-pandeya-898', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 898, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ '*' => true, 'id' => false ], '[dirty]' => [], '[original]' => [], '[virtual]' => [], '[hasErrors]' => false, '[errors]' => [], '[invalid]' => [], '[repository]' => 'Articles' } $articleid = (int) 825 $metaTitle = 'LATEST NEWS UPDATES | Health ministry to import 1.5 million doses of H1N1 vaccine by Radhieka Pandeya' $metaKeywords = null $metaDesc = ' The health ministry has placed an order to import 1.5 million doses of the swine flu vaccine into India, which will be available in January. This is contrary to the government&rsquo;s earlier claims of importing four million doses of the...' $disp = '<p align="justify"><font >The health ministry has placed an order to import 1.5 million doses of the swine flu vaccine into India, which will be available in January. </font></p><p align="justify"><font >This is contrary to the government&rsquo;s earlier claims of importing four million doses of the vaccine. Indian manufacturers will now supply the remaining doses. </font></p><p align="justify"><font >&ldquo;We have placed an order for importing 1.5 million doses already,&rdquo; said Vineet Chawdhry, joint secretary, health ministry. &ldquo;Indigenous production of the vaccine will be ready by March, so we will have that available soon as well.&rdquo;</font></p><p align="justify"><font >The health ministry has been trying to make the vaccine available in India for the last two months and had sped up regulatory approvals for studies to be conducted on the safety of the vaccine. </font></p><p align="justify"><font >Chawdhry said India&rsquo;s Zydus Cadila would have the vaccine ready by March, so the government would not need to import batches, which is why an order for only 1.5 million doses has been placed at the moment.</font></p><p align="justify"><font >Cadila is not one of the three Indian drug makers being supported by the government to develop and manufacture the H1N1 flu vaccine. The ones that are supported are Serum Institute of India Ltd, Bharat Biotech International Ltd and Panacea Biotech Ltd. According to ministry officials, who declined to be named, vaccines of these three firms will not be ready before April.</font></p><p align="justify"><font >Chawdhry declined to name the overseas company that will supply the vaccine, citing a confidentiality clause. Ministry officials, however, have been in talks with four international vaccine makers&mdash;GlaxoSmithKline Plc (GSK), Baxter International Inc., Novartis AG and Sanofi Pasteur SA. </font></p><p align="justify"><font >On 1 December, Mint reported that the vaccines could be available in the country by the end of the month following approvals by the Indian regulator for human clinical trials to two multinational drug makers, GSK and Baxter, while among Indian vaccine makers, only Zydus Cadila had submitted the clinical trial protocol to the regulator to conduct trials of its vaccine candidate. </font></p><p align="justify"><font >The vaccine, said Chawdhry, would initially be made available to healthcare workers who come in direct contact with the virus and are at greater risk of being infected by it. It would could later be made available to the general public, either through government or private channels, he said.</font></p><p align="justify"><font >As on 29 December, India reported 25,572 confirmed cases of swine flu, of which 898 resulted in death. Delhi reported 8,306 cases, the highest among the states. </font></p><p align="justify"><font >According to World Health Organisation director general Margaret Chan, while the worst of the swine flu outbreak is over in the US and Canada, there is still intensive virus activity in some countries including India. Chan also warned that the virus could still mutate and countries must &ldquo;guard against complacency&rdquo;.<br /></font></p>' $lang = 'English' $SITE_URL = 'https://im4change.in/' $site_title = 'im4change' $adminprix = 'admin'</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8 Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413 Cake\View\View::_render() - CORE/src/View/View.php, line 1374 Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927 Cake\View\View::render() - CORE/src/View/View.php, line 885 Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/health-ministry-to-import-1-5-million-doses-of-h1n1-vaccine-by-radhieka-pandeya-898.html"/> <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/> <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css" media="all"/> <title>LATEST NEWS UPDATES | Health ministry to import 1.5 million doses of H1N1 vaccine by Radhieka Pandeya | Im4change.org</title> <meta name="description" content=" The health ministry has placed an order to import 1.5 million doses of the swine flu vaccine into India, which will be available in January. This is contrary to the government’s earlier claims of importing four million doses of the..."/> <script src="https://im4change.in/js/jquery-1.10.2.js"></script> <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script> <script language="javascript" type="text/javascript"> $(document).ready(function () { var img = $("img")[0]; // Get my img elem var pic_real_width, pic_real_height; $("<img/>") // Make in memory copy of image to avoid css issues .attr("src", $(img).attr("src")) .load(function () { pic_real_width = this.width; // Note: $(this).width() will not pic_real_height = this.height; // work for in memory images. }); }); </script> <style type="text/css"> @media screen { div.divFooter { display: block; } } @media print { .printbutton { display: none !important; } } </style> </head> <body> <table cellpadding="0" cellspacing="0" border="0" width="98%" align="center"> <tr> <td class="top_bg"> <div class="divFooter"> <img src="https://im4change.in/images/logo1.jpg" height="59" border="0" alt="Resource centre on India's rural distress" style="padding-top:14px;"/> </div> </td> </tr> <tr> <td id="topspace"> </td> </tr> <tr id="topspace"> <td> </td> </tr> <tr> <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> <tr> <td width="100%"> <h1 class="news_headlines" style="font-style:normal"> <strong>Health ministry to import 1.5 million doses of H1N1 vaccine by Radhieka Pandeya</strong></h1> </td> </tr> <tr> <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3"> <p align="justify"><font >The health ministry has placed an order to import 1.5 million doses of the swine flu vaccine into India, which will be available in January. </font></p><p align="justify"><font >This is contrary to the government’s earlier claims of importing four million doses of the vaccine. Indian manufacturers will now supply the remaining doses. </font></p><p align="justify"><font >“We have placed an order for importing 1.5 million doses already,” said Vineet Chawdhry, joint secretary, health ministry. “Indigenous production of the vaccine will be ready by March, so we will have that available soon as well.”</font></p><p align="justify"><font >The health ministry has been trying to make the vaccine available in India for the last two months and had sped up regulatory approvals for studies to be conducted on the safety of the vaccine. </font></p><p align="justify"><font >Chawdhry said India’s Zydus Cadila would have the vaccine ready by March, so the government would not need to import batches, which is why an order for only 1.5 million doses has been placed at the moment.</font></p><p align="justify"><font >Cadila is not one of the three Indian drug makers being supported by the government to develop and manufacture the H1N1 flu vaccine. The ones that are supported are Serum Institute of India Ltd, Bharat Biotech International Ltd and Panacea Biotech Ltd. According to ministry officials, who declined to be named, vaccines of these three firms will not be ready before April.</font></p><p align="justify"><font >Chawdhry declined to name the overseas company that will supply the vaccine, citing a confidentiality clause. Ministry officials, however, have been in talks with four international vaccine makers—GlaxoSmithKline Plc (GSK), Baxter International Inc., Novartis AG and Sanofi Pasteur SA. </font></p><p align="justify"><font >On 1 December, Mint reported that the vaccines could be available in the country by the end of the month following approvals by the Indian regulator for human clinical trials to two multinational drug makers, GSK and Baxter, while among Indian vaccine makers, only Zydus Cadila had submitted the clinical trial protocol to the regulator to conduct trials of its vaccine candidate. </font></p><p align="justify"><font >The vaccine, said Chawdhry, would initially be made available to healthcare workers who come in direct contact with the virus and are at greater risk of being infected by it. It would could later be made available to the general public, either through government or private channels, he said.</font></p><p align="justify"><font >As on 29 December, India reported 25,572 confirmed cases of swine flu, of which 898 resulted in death. Delhi reported 8,306 cases, the highest among the states. </font></p><p align="justify"><font >According to World Health Organisation director general Margaret Chan, while the worst of the swine flu outbreak is over in the US and Canada, there is still intensive virus activity in some countries including India. Chan also warned that the virus could still mutate and countries must “guard against complacency”.<br /></font></p> </font> </td> </tr> <tr> <td> </td> </tr> <tr> <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> </table></body> </html>' } $maxBufferLength = (int) 8192 $file = '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php' $line = (int) 853 $message = 'Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853'Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 48 Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141 [main] - ROOT/webroot/index.php, line 39
Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]Code Context$response->getStatusCode(),
($reasonPhrase ? ' ' . $reasonPhrase : '')
));
$response = object(Cake\Http\Response) { 'status' => (int) 200, 'contentType' => 'text/html', 'headers' => [ 'Content-Type' => [ [maximum depth reached] ] ], 'file' => null, 'fileRange' => [], 'cookies' => object(Cake\Http\Cookie\CookieCollection) {}, 'cacheDirectives' => [], 'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"> <html xmlns="http://www.w3.org/1999/xhtml"> <head> <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr680262adf319c-trace').style.display = (document.getElementById('cakeErr680262adf319c-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr680262adf319c-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr680262adf319c-code').style.display = (document.getElementById('cakeErr680262adf319c-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr680262adf319c-context').style.display = (document.getElementById('cakeErr680262adf319c-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr680262adf319c-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700"><</span><span style="color: #0000BB">head</span><span style="color: #007700">> </span></span></code> <span class="code-highlight"><code><span style="color: #000000"> <link rel="canonical" href="<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">); </span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">category</span><span style="color: #007700">-></span><span style="color: #0000BB">slug</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>/<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">seo_url</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>.html"/> </span></code></span> <code><span style="color: #000000"><span style="color: #0000BB"> </span><span style="color: #007700"><</span><span style="color: #0000BB">meta http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type" </span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html; charset=utf-8"</span><span style="color: #007700">/> </span></span></code></pre><pre id="cakeErr680262adf319c-context" class="cake-context" style="display: none;">$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp' $dataForView = [ 'article_current' => object(App\Model\Entity\Article) { 'id' => (int) 825, 'title' => 'Health ministry to import 1.5 million doses of H1N1 vaccine by Radhieka Pandeya', 'subheading' => '', 'description' => '<p align="justify"> <font face="arial,helvetica,sans-serif" size="3">The health ministry has placed an order to import 1.5 million doses of the swine flu vaccine into India, which will be available in January. </font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">This is contrary to the government&rsquo;s earlier claims of importing four million doses of the vaccine. Indian manufacturers will now supply the remaining doses. </font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">&ldquo;We have placed an order for importing 1.5 million doses already,&rdquo; said Vineet Chawdhry, joint secretary, health ministry. &ldquo;Indigenous production of the vaccine will be ready by March, so we will have that available soon as well.&rdquo;</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">The health ministry has been trying to make the vaccine available in India for the last two months and had sped up regulatory approvals for studies to be conducted on the safety of the vaccine. </font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">Chawdhry said India&rsquo;s Zydus Cadila would have the vaccine ready by March, so the government would not need to import batches, which is why an order for only 1.5 million doses has been placed at the moment.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">Cadila is not one of the three Indian drug makers being supported by the government to develop and manufacture the H1N1 flu vaccine. The ones that are supported are Serum Institute of India Ltd, Bharat Biotech International Ltd and Panacea Biotech Ltd. According to ministry officials, who declined to be named, vaccines of these three firms will not be ready before April.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">Chawdhry declined to name the overseas company that will supply the vaccine, citing a confidentiality clause. Ministry officials, however, have been in talks with four international vaccine makers&mdash;GlaxoSmithKline Plc (GSK), Baxter International Inc., Novartis AG and Sanofi Pasteur SA. </font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">On 1 December, Mint reported that the vaccines could be available in the country by the end of the month following approvals by the Indian regulator for human clinical trials to two multinational drug makers, GSK and Baxter, while among Indian vaccine makers, only Zydus Cadila had submitted the clinical trial protocol to the regulator to conduct trials of its vaccine candidate. </font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">The vaccine, said Chawdhry, would initially be made available to healthcare workers who come in direct contact with the virus and are at greater risk of being infected by it. It would could later be made available to the general public, either through government or private channels, he said.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">As on 29 December, India reported 25,572 confirmed cases of swine flu, of which 898 resulted in death. Delhi reported 8,306 cases, the highest among the states. </font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">According to World Health Organisation director general Margaret Chan, while the worst of the swine flu outbreak is over in the US and Canada, there is still intensive virus activity in some countries including India. Chan also warned that the virus could still mutate and countries must &ldquo;guard against complacency&rdquo;.<br /> </font> </p> ', 'credit_writer' => 'Live Mint, 30 December, 2009, http://www.livemint.com/2009/12/30204656/Health-ministry-to-import-15.html', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'health-ministry-to-import-1-5-million-doses-of-h1n1-vaccine-by-radhieka-pandeya-898', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 898, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [[maximum depth reached]], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ [maximum depth reached] ], '[dirty]' => [[maximum depth reached]], '[original]' => [[maximum depth reached]], '[virtual]' => [[maximum depth reached]], '[hasErrors]' => false, '[errors]' => [[maximum depth reached]], '[invalid]' => [[maximum depth reached]], '[repository]' => 'Articles' }, 'articleid' => (int) 825, 'metaTitle' => 'LATEST NEWS UPDATES | Health ministry to import 1.5 million doses of H1N1 vaccine by Radhieka Pandeya', 'metaKeywords' => null, 'metaDesc' => ' The health ministry has placed an order to import 1.5 million doses of the swine flu vaccine into India, which will be available in January. This is contrary to the government&rsquo;s earlier claims of importing four million doses of the...', 'disp' => '<p align="justify"><font >The health ministry has placed an order to import 1.5 million doses of the swine flu vaccine into India, which will be available in January. </font></p><p align="justify"><font >This is contrary to the government&rsquo;s earlier claims of importing four million doses of the vaccine. Indian manufacturers will now supply the remaining doses. </font></p><p align="justify"><font >&ldquo;We have placed an order for importing 1.5 million doses already,&rdquo; said Vineet Chawdhry, joint secretary, health ministry. &ldquo;Indigenous production of the vaccine will be ready by March, so we will have that available soon as well.&rdquo;</font></p><p align="justify"><font >The health ministry has been trying to make the vaccine available in India for the last two months and had sped up regulatory approvals for studies to be conducted on the safety of the vaccine. </font></p><p align="justify"><font >Chawdhry said India&rsquo;s Zydus Cadila would have the vaccine ready by March, so the government would not need to import batches, which is why an order for only 1.5 million doses has been placed at the moment.</font></p><p align="justify"><font >Cadila is not one of the three Indian drug makers being supported by the government to develop and manufacture the H1N1 flu vaccine. The ones that are supported are Serum Institute of India Ltd, Bharat Biotech International Ltd and Panacea Biotech Ltd. According to ministry officials, who declined to be named, vaccines of these three firms will not be ready before April.</font></p><p align="justify"><font >Chawdhry declined to name the overseas company that will supply the vaccine, citing a confidentiality clause. Ministry officials, however, have been in talks with four international vaccine makers&mdash;GlaxoSmithKline Plc (GSK), Baxter International Inc., Novartis AG and Sanofi Pasteur SA. </font></p><p align="justify"><font >On 1 December, Mint reported that the vaccines could be available in the country by the end of the month following approvals by the Indian regulator for human clinical trials to two multinational drug makers, GSK and Baxter, while among Indian vaccine makers, only Zydus Cadila had submitted the clinical trial protocol to the regulator to conduct trials of its vaccine candidate. </font></p><p align="justify"><font >The vaccine, said Chawdhry, would initially be made available to healthcare workers who come in direct contact with the virus and are at greater risk of being infected by it. It would could later be made available to the general public, either through government or private channels, he said.</font></p><p align="justify"><font >As on 29 December, India reported 25,572 confirmed cases of swine flu, of which 898 resulted in death. Delhi reported 8,306 cases, the highest among the states. </font></p><p align="justify"><font >According to World Health Organisation director general Margaret Chan, while the worst of the swine flu outbreak is over in the US and Canada, there is still intensive virus activity in some countries including India. Chan also warned that the virus could still mutate and countries must &ldquo;guard against complacency&rdquo;.<br /></font></p>', 'lang' => 'English', 'SITE_URL' => 'https://im4change.in/', 'site_title' => 'im4change', 'adminprix' => 'admin' ] $article_current = object(App\Model\Entity\Article) { 'id' => (int) 825, 'title' => 'Health ministry to import 1.5 million doses of H1N1 vaccine by Radhieka Pandeya', 'subheading' => '', 'description' => '<p align="justify"> <font face="arial,helvetica,sans-serif" size="3">The health ministry has placed an order to import 1.5 million doses of the swine flu vaccine into India, which will be available in January. </font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">This is contrary to the government&rsquo;s earlier claims of importing four million doses of the vaccine. Indian manufacturers will now supply the remaining doses. </font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">&ldquo;We have placed an order for importing 1.5 million doses already,&rdquo; said Vineet Chawdhry, joint secretary, health ministry. &ldquo;Indigenous production of the vaccine will be ready by March, so we will have that available soon as well.&rdquo;</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">The health ministry has been trying to make the vaccine available in India for the last two months and had sped up regulatory approvals for studies to be conducted on the safety of the vaccine. </font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">Chawdhry said India&rsquo;s Zydus Cadila would have the vaccine ready by March, so the government would not need to import batches, which is why an order for only 1.5 million doses has been placed at the moment.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">Cadila is not one of the three Indian drug makers being supported by the government to develop and manufacture the H1N1 flu vaccine. The ones that are supported are Serum Institute of India Ltd, Bharat Biotech International Ltd and Panacea Biotech Ltd. According to ministry officials, who declined to be named, vaccines of these three firms will not be ready before April.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">Chawdhry declined to name the overseas company that will supply the vaccine, citing a confidentiality clause. Ministry officials, however, have been in talks with four international vaccine makers&mdash;GlaxoSmithKline Plc (GSK), Baxter International Inc., Novartis AG and Sanofi Pasteur SA. </font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">On 1 December, Mint reported that the vaccines could be available in the country by the end of the month following approvals by the Indian regulator for human clinical trials to two multinational drug makers, GSK and Baxter, while among Indian vaccine makers, only Zydus Cadila had submitted the clinical trial protocol to the regulator to conduct trials of its vaccine candidate. </font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">The vaccine, said Chawdhry, would initially be made available to healthcare workers who come in direct contact with the virus and are at greater risk of being infected by it. It would could later be made available to the general public, either through government or private channels, he said.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">As on 29 December, India reported 25,572 confirmed cases of swine flu, of which 898 resulted in death. Delhi reported 8,306 cases, the highest among the states. </font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">According to World Health Organisation director general Margaret Chan, while the worst of the swine flu outbreak is over in the US and Canada, there is still intensive virus activity in some countries including India. Chan also warned that the virus could still mutate and countries must &ldquo;guard against complacency&rdquo;.<br /> </font> </p> ', 'credit_writer' => 'Live Mint, 30 December, 2009, http://www.livemint.com/2009/12/30204656/Health-ministry-to-import-15.html', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'health-ministry-to-import-1-5-million-doses-of-h1n1-vaccine-by-radhieka-pandeya-898', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 898, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ '*' => true, 'id' => false ], '[dirty]' => [], '[original]' => [], '[virtual]' => [], '[hasErrors]' => false, '[errors]' => [], '[invalid]' => [], '[repository]' => 'Articles' } $articleid = (int) 825 $metaTitle = 'LATEST NEWS UPDATES | Health ministry to import 1.5 million doses of H1N1 vaccine by Radhieka Pandeya' $metaKeywords = null $metaDesc = ' The health ministry has placed an order to import 1.5 million doses of the swine flu vaccine into India, which will be available in January. This is contrary to the government&rsquo;s earlier claims of importing four million doses of the...' $disp = '<p align="justify"><font >The health ministry has placed an order to import 1.5 million doses of the swine flu vaccine into India, which will be available in January. </font></p><p align="justify"><font >This is contrary to the government&rsquo;s earlier claims of importing four million doses of the vaccine. Indian manufacturers will now supply the remaining doses. </font></p><p align="justify"><font >&ldquo;We have placed an order for importing 1.5 million doses already,&rdquo; said Vineet Chawdhry, joint secretary, health ministry. &ldquo;Indigenous production of the vaccine will be ready by March, so we will have that available soon as well.&rdquo;</font></p><p align="justify"><font >The health ministry has been trying to make the vaccine available in India for the last two months and had sped up regulatory approvals for studies to be conducted on the safety of the vaccine. </font></p><p align="justify"><font >Chawdhry said India&rsquo;s Zydus Cadila would have the vaccine ready by March, so the government would not need to import batches, which is why an order for only 1.5 million doses has been placed at the moment.</font></p><p align="justify"><font >Cadila is not one of the three Indian drug makers being supported by the government to develop and manufacture the H1N1 flu vaccine. The ones that are supported are Serum Institute of India Ltd, Bharat Biotech International Ltd and Panacea Biotech Ltd. According to ministry officials, who declined to be named, vaccines of these three firms will not be ready before April.</font></p><p align="justify"><font >Chawdhry declined to name the overseas company that will supply the vaccine, citing a confidentiality clause. Ministry officials, however, have been in talks with four international vaccine makers&mdash;GlaxoSmithKline Plc (GSK), Baxter International Inc., Novartis AG and Sanofi Pasteur SA. </font></p><p align="justify"><font >On 1 December, Mint reported that the vaccines could be available in the country by the end of the month following approvals by the Indian regulator for human clinical trials to two multinational drug makers, GSK and Baxter, while among Indian vaccine makers, only Zydus Cadila had submitted the clinical trial protocol to the regulator to conduct trials of its vaccine candidate. </font></p><p align="justify"><font >The vaccine, said Chawdhry, would initially be made available to healthcare workers who come in direct contact with the virus and are at greater risk of being infected by it. It would could later be made available to the general public, either through government or private channels, he said.</font></p><p align="justify"><font >As on 29 December, India reported 25,572 confirmed cases of swine flu, of which 898 resulted in death. Delhi reported 8,306 cases, the highest among the states. </font></p><p align="justify"><font >According to World Health Organisation director general Margaret Chan, while the worst of the swine flu outbreak is over in the US and Canada, there is still intensive virus activity in some countries including India. Chan also warned that the virus could still mutate and countries must &ldquo;guard against complacency&rdquo;.<br /></font></p>' $lang = 'English' $SITE_URL = 'https://im4change.in/' $site_title = 'im4change' $adminprix = 'admin'</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8 Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413 Cake\View\View::_render() - CORE/src/View/View.php, line 1374 Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927 Cake\View\View::render() - CORE/src/View/View.php, line 885 Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/health-ministry-to-import-1-5-million-doses-of-h1n1-vaccine-by-radhieka-pandeya-898.html"/> <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/> <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css" media="all"/> <title>LATEST NEWS UPDATES | Health ministry to import 1.5 million doses of H1N1 vaccine by Radhieka Pandeya | Im4change.org</title> <meta name="description" content=" The health ministry has placed an order to import 1.5 million doses of the swine flu vaccine into India, which will be available in January. This is contrary to the government’s earlier claims of importing four million doses of the..."/> <script src="https://im4change.in/js/jquery-1.10.2.js"></script> <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script> <script language="javascript" type="text/javascript"> $(document).ready(function () { var img = $("img")[0]; // Get my img elem var pic_real_width, pic_real_height; $("<img/>") // Make in memory copy of image to avoid css issues .attr("src", $(img).attr("src")) .load(function () { pic_real_width = this.width; // Note: $(this).width() will not pic_real_height = this.height; // work for in memory images. }); }); </script> <style type="text/css"> @media screen { div.divFooter { display: block; } } @media print { .printbutton { display: none !important; } } </style> </head> <body> <table cellpadding="0" cellspacing="0" border="0" width="98%" align="center"> <tr> <td class="top_bg"> <div class="divFooter"> <img src="https://im4change.in/images/logo1.jpg" height="59" border="0" alt="Resource centre on India's rural distress" style="padding-top:14px;"/> </div> </td> </tr> <tr> <td id="topspace"> </td> </tr> <tr id="topspace"> <td> </td> </tr> <tr> <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> <tr> <td width="100%"> <h1 class="news_headlines" style="font-style:normal"> <strong>Health ministry to import 1.5 million doses of H1N1 vaccine by Radhieka Pandeya</strong></h1> </td> </tr> <tr> <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3"> <p align="justify"><font >The health ministry has placed an order to import 1.5 million doses of the swine flu vaccine into India, which will be available in January. </font></p><p align="justify"><font >This is contrary to the government’s earlier claims of importing four million doses of the vaccine. Indian manufacturers will now supply the remaining doses. </font></p><p align="justify"><font >“We have placed an order for importing 1.5 million doses already,” said Vineet Chawdhry, joint secretary, health ministry. “Indigenous production of the vaccine will be ready by March, so we will have that available soon as well.”</font></p><p align="justify"><font >The health ministry has been trying to make the vaccine available in India for the last two months and had sped up regulatory approvals for studies to be conducted on the safety of the vaccine. </font></p><p align="justify"><font >Chawdhry said India’s Zydus Cadila would have the vaccine ready by March, so the government would not need to import batches, which is why an order for only 1.5 million doses has been placed at the moment.</font></p><p align="justify"><font >Cadila is not one of the three Indian drug makers being supported by the government to develop and manufacture the H1N1 flu vaccine. The ones that are supported are Serum Institute of India Ltd, Bharat Biotech International Ltd and Panacea Biotech Ltd. According to ministry officials, who declined to be named, vaccines of these three firms will not be ready before April.</font></p><p align="justify"><font >Chawdhry declined to name the overseas company that will supply the vaccine, citing a confidentiality clause. Ministry officials, however, have been in talks with four international vaccine makers—GlaxoSmithKline Plc (GSK), Baxter International Inc., Novartis AG and Sanofi Pasteur SA. </font></p><p align="justify"><font >On 1 December, Mint reported that the vaccines could be available in the country by the end of the month following approvals by the Indian regulator for human clinical trials to two multinational drug makers, GSK and Baxter, while among Indian vaccine makers, only Zydus Cadila had submitted the clinical trial protocol to the regulator to conduct trials of its vaccine candidate. </font></p><p align="justify"><font >The vaccine, said Chawdhry, would initially be made available to healthcare workers who come in direct contact with the virus and are at greater risk of being infected by it. It would could later be made available to the general public, either through government or private channels, he said.</font></p><p align="justify"><font >As on 29 December, India reported 25,572 confirmed cases of swine flu, of which 898 resulted in death. Delhi reported 8,306 cases, the highest among the states. </font></p><p align="justify"><font >According to World Health Organisation director general Margaret Chan, while the worst of the swine flu outbreak is over in the US and Canada, there is still intensive virus activity in some countries including India. Chan also warned that the virus could still mutate and countries must “guard against complacency”.<br /></font></p> </font> </td> </tr> <tr> <td> </td> </tr> <tr> <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> </table></body> </html>' } $reasonPhrase = 'OK'header - [internal], line ?? Cake\Http\ResponseEmitter::emitStatusLine() - CORE/src/Http/ResponseEmitter.php, line 148 Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 54 Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141 [main] - ROOT/webroot/index.php, line 39
Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]Notice (8): Undefined variable: urlPrefix [APP/Template/Layout/printlayout.ctp, line 8]Code Context$value
), $first);
$first = false;
$response = object(Cake\Http\Response) { 'status' => (int) 200, 'contentType' => 'text/html', 'headers' => [ 'Content-Type' => [ [maximum depth reached] ] ], 'file' => null, 'fileRange' => [], 'cookies' => object(Cake\Http\Cookie\CookieCollection) {}, 'cacheDirectives' => [], 'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"> <html xmlns="http://www.w3.org/1999/xhtml"> <head> <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr680262adf319c-trace').style.display = (document.getElementById('cakeErr680262adf319c-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr680262adf319c-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr680262adf319c-code').style.display = (document.getElementById('cakeErr680262adf319c-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr680262adf319c-context').style.display = (document.getElementById('cakeErr680262adf319c-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr680262adf319c-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700"><</span><span style="color: #0000BB">head</span><span style="color: #007700">> </span></span></code> <span class="code-highlight"><code><span style="color: #000000"> <link rel="canonical" href="<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">); </span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">category</span><span style="color: #007700">-></span><span style="color: #0000BB">slug</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>/<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">seo_url</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>.html"/> </span></code></span> <code><span style="color: #000000"><span style="color: #0000BB"> </span><span style="color: #007700"><</span><span style="color: #0000BB">meta http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type" </span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html; charset=utf-8"</span><span style="color: #007700">/> </span></span></code></pre><pre id="cakeErr680262adf319c-context" class="cake-context" style="display: none;">$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp' $dataForView = [ 'article_current' => object(App\Model\Entity\Article) { 'id' => (int) 825, 'title' => 'Health ministry to import 1.5 million doses of H1N1 vaccine by Radhieka Pandeya', 'subheading' => '', 'description' => '<p align="justify"> <font face="arial,helvetica,sans-serif" size="3">The health ministry has placed an order to import 1.5 million doses of the swine flu vaccine into India, which will be available in January. </font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">This is contrary to the government&rsquo;s earlier claims of importing four million doses of the vaccine. Indian manufacturers will now supply the remaining doses. </font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">&ldquo;We have placed an order for importing 1.5 million doses already,&rdquo; said Vineet Chawdhry, joint secretary, health ministry. &ldquo;Indigenous production of the vaccine will be ready by March, so we will have that available soon as well.&rdquo;</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">The health ministry has been trying to make the vaccine available in India for the last two months and had sped up regulatory approvals for studies to be conducted on the safety of the vaccine. </font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">Chawdhry said India&rsquo;s Zydus Cadila would have the vaccine ready by March, so the government would not need to import batches, which is why an order for only 1.5 million doses has been placed at the moment.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">Cadila is not one of the three Indian drug makers being supported by the government to develop and manufacture the H1N1 flu vaccine. The ones that are supported are Serum Institute of India Ltd, Bharat Biotech International Ltd and Panacea Biotech Ltd. According to ministry officials, who declined to be named, vaccines of these three firms will not be ready before April.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">Chawdhry declined to name the overseas company that will supply the vaccine, citing a confidentiality clause. Ministry officials, however, have been in talks with four international vaccine makers&mdash;GlaxoSmithKline Plc (GSK), Baxter International Inc., Novartis AG and Sanofi Pasteur SA. </font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">On 1 December, Mint reported that the vaccines could be available in the country by the end of the month following approvals by the Indian regulator for human clinical trials to two multinational drug makers, GSK and Baxter, while among Indian vaccine makers, only Zydus Cadila had submitted the clinical trial protocol to the regulator to conduct trials of its vaccine candidate. </font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">The vaccine, said Chawdhry, would initially be made available to healthcare workers who come in direct contact with the virus and are at greater risk of being infected by it. It would could later be made available to the general public, either through government or private channels, he said.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">As on 29 December, India reported 25,572 confirmed cases of swine flu, of which 898 resulted in death. Delhi reported 8,306 cases, the highest among the states. </font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">According to World Health Organisation director general Margaret Chan, while the worst of the swine flu outbreak is over in the US and Canada, there is still intensive virus activity in some countries including India. Chan also warned that the virus could still mutate and countries must &ldquo;guard against complacency&rdquo;.<br /> </font> </p> ', 'credit_writer' => 'Live Mint, 30 December, 2009, http://www.livemint.com/2009/12/30204656/Health-ministry-to-import-15.html', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'health-ministry-to-import-1-5-million-doses-of-h1n1-vaccine-by-radhieka-pandeya-898', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 898, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [[maximum depth reached]], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ [maximum depth reached] ], '[dirty]' => [[maximum depth reached]], '[original]' => [[maximum depth reached]], '[virtual]' => [[maximum depth reached]], '[hasErrors]' => false, '[errors]' => [[maximum depth reached]], '[invalid]' => [[maximum depth reached]], '[repository]' => 'Articles' }, 'articleid' => (int) 825, 'metaTitle' => 'LATEST NEWS UPDATES | Health ministry to import 1.5 million doses of H1N1 vaccine by Radhieka Pandeya', 'metaKeywords' => null, 'metaDesc' => ' The health ministry has placed an order to import 1.5 million doses of the swine flu vaccine into India, which will be available in January. This is contrary to the government&rsquo;s earlier claims of importing four million doses of the...', 'disp' => '<p align="justify"><font >The health ministry has placed an order to import 1.5 million doses of the swine flu vaccine into India, which will be available in January. </font></p><p align="justify"><font >This is contrary to the government&rsquo;s earlier claims of importing four million doses of the vaccine. Indian manufacturers will now supply the remaining doses. </font></p><p align="justify"><font >&ldquo;We have placed an order for importing 1.5 million doses already,&rdquo; said Vineet Chawdhry, joint secretary, health ministry. &ldquo;Indigenous production of the vaccine will be ready by March, so we will have that available soon as well.&rdquo;</font></p><p align="justify"><font >The health ministry has been trying to make the vaccine available in India for the last two months and had sped up regulatory approvals for studies to be conducted on the safety of the vaccine. </font></p><p align="justify"><font >Chawdhry said India&rsquo;s Zydus Cadila would have the vaccine ready by March, so the government would not need to import batches, which is why an order for only 1.5 million doses has been placed at the moment.</font></p><p align="justify"><font >Cadila is not one of the three Indian drug makers being supported by the government to develop and manufacture the H1N1 flu vaccine. The ones that are supported are Serum Institute of India Ltd, Bharat Biotech International Ltd and Panacea Biotech Ltd. According to ministry officials, who declined to be named, vaccines of these three firms will not be ready before April.</font></p><p align="justify"><font >Chawdhry declined to name the overseas company that will supply the vaccine, citing a confidentiality clause. Ministry officials, however, have been in talks with four international vaccine makers&mdash;GlaxoSmithKline Plc (GSK), Baxter International Inc., Novartis AG and Sanofi Pasteur SA. </font></p><p align="justify"><font >On 1 December, Mint reported that the vaccines could be available in the country by the end of the month following approvals by the Indian regulator for human clinical trials to two multinational drug makers, GSK and Baxter, while among Indian vaccine makers, only Zydus Cadila had submitted the clinical trial protocol to the regulator to conduct trials of its vaccine candidate. </font></p><p align="justify"><font >The vaccine, said Chawdhry, would initially be made available to healthcare workers who come in direct contact with the virus and are at greater risk of being infected by it. It would could later be made available to the general public, either through government or private channels, he said.</font></p><p align="justify"><font >As on 29 December, India reported 25,572 confirmed cases of swine flu, of which 898 resulted in death. Delhi reported 8,306 cases, the highest among the states. </font></p><p align="justify"><font >According to World Health Organisation director general Margaret Chan, while the worst of the swine flu outbreak is over in the US and Canada, there is still intensive virus activity in some countries including India. Chan also warned that the virus could still mutate and countries must &ldquo;guard against complacency&rdquo;.<br /></font></p>', 'lang' => 'English', 'SITE_URL' => 'https://im4change.in/', 'site_title' => 'im4change', 'adminprix' => 'admin' ] $article_current = object(App\Model\Entity\Article) { 'id' => (int) 825, 'title' => 'Health ministry to import 1.5 million doses of H1N1 vaccine by Radhieka Pandeya', 'subheading' => '', 'description' => '<p align="justify"> <font face="arial,helvetica,sans-serif" size="3">The health ministry has placed an order to import 1.5 million doses of the swine flu vaccine into India, which will be available in January. </font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">This is contrary to the government&rsquo;s earlier claims of importing four million doses of the vaccine. Indian manufacturers will now supply the remaining doses. </font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">&ldquo;We have placed an order for importing 1.5 million doses already,&rdquo; said Vineet Chawdhry, joint secretary, health ministry. &ldquo;Indigenous production of the vaccine will be ready by March, so we will have that available soon as well.&rdquo;</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">The health ministry has been trying to make the vaccine available in India for the last two months and had sped up regulatory approvals for studies to be conducted on the safety of the vaccine. </font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">Chawdhry said India&rsquo;s Zydus Cadila would have the vaccine ready by March, so the government would not need to import batches, which is why an order for only 1.5 million doses has been placed at the moment.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">Cadila is not one of the three Indian drug makers being supported by the government to develop and manufacture the H1N1 flu vaccine. The ones that are supported are Serum Institute of India Ltd, Bharat Biotech International Ltd and Panacea Biotech Ltd. According to ministry officials, who declined to be named, vaccines of these three firms will not be ready before April.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">Chawdhry declined to name the overseas company that will supply the vaccine, citing a confidentiality clause. Ministry officials, however, have been in talks with four international vaccine makers&mdash;GlaxoSmithKline Plc (GSK), Baxter International Inc., Novartis AG and Sanofi Pasteur SA. </font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">On 1 December, Mint reported that the vaccines could be available in the country by the end of the month following approvals by the Indian regulator for human clinical trials to two multinational drug makers, GSK and Baxter, while among Indian vaccine makers, only Zydus Cadila had submitted the clinical trial protocol to the regulator to conduct trials of its vaccine candidate. </font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">The vaccine, said Chawdhry, would initially be made available to healthcare workers who come in direct contact with the virus and are at greater risk of being infected by it. It would could later be made available to the general public, either through government or private channels, he said.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">As on 29 December, India reported 25,572 confirmed cases of swine flu, of which 898 resulted in death. Delhi reported 8,306 cases, the highest among the states. </font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">According to World Health Organisation director general Margaret Chan, while the worst of the swine flu outbreak is over in the US and Canada, there is still intensive virus activity in some countries including India. Chan also warned that the virus could still mutate and countries must &ldquo;guard against complacency&rdquo;.<br /> </font> </p> ', 'credit_writer' => 'Live Mint, 30 December, 2009, http://www.livemint.com/2009/12/30204656/Health-ministry-to-import-15.html', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'health-ministry-to-import-1-5-million-doses-of-h1n1-vaccine-by-radhieka-pandeya-898', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 898, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ '*' => true, 'id' => false ], '[dirty]' => [], '[original]' => [], '[virtual]' => [], '[hasErrors]' => false, '[errors]' => [], '[invalid]' => [], '[repository]' => 'Articles' } $articleid = (int) 825 $metaTitle = 'LATEST NEWS UPDATES | Health ministry to import 1.5 million doses of H1N1 vaccine by Radhieka Pandeya' $metaKeywords = null $metaDesc = ' The health ministry has placed an order to import 1.5 million doses of the swine flu vaccine into India, which will be available in January. This is contrary to the government&rsquo;s earlier claims of importing four million doses of the...' $disp = '<p align="justify"><font >The health ministry has placed an order to import 1.5 million doses of the swine flu vaccine into India, which will be available in January. </font></p><p align="justify"><font >This is contrary to the government&rsquo;s earlier claims of importing four million doses of the vaccine. Indian manufacturers will now supply the remaining doses. </font></p><p align="justify"><font >&ldquo;We have placed an order for importing 1.5 million doses already,&rdquo; said Vineet Chawdhry, joint secretary, health ministry. &ldquo;Indigenous production of the vaccine will be ready by March, so we will have that available soon as well.&rdquo;</font></p><p align="justify"><font >The health ministry has been trying to make the vaccine available in India for the last two months and had sped up regulatory approvals for studies to be conducted on the safety of the vaccine. </font></p><p align="justify"><font >Chawdhry said India&rsquo;s Zydus Cadila would have the vaccine ready by March, so the government would not need to import batches, which is why an order for only 1.5 million doses has been placed at the moment.</font></p><p align="justify"><font >Cadila is not one of the three Indian drug makers being supported by the government to develop and manufacture the H1N1 flu vaccine. The ones that are supported are Serum Institute of India Ltd, Bharat Biotech International Ltd and Panacea Biotech Ltd. According to ministry officials, who declined to be named, vaccines of these three firms will not be ready before April.</font></p><p align="justify"><font >Chawdhry declined to name the overseas company that will supply the vaccine, citing a confidentiality clause. Ministry officials, however, have been in talks with four international vaccine makers&mdash;GlaxoSmithKline Plc (GSK), Baxter International Inc., Novartis AG and Sanofi Pasteur SA. </font></p><p align="justify"><font >On 1 December, Mint reported that the vaccines could be available in the country by the end of the month following approvals by the Indian regulator for human clinical trials to two multinational drug makers, GSK and Baxter, while among Indian vaccine makers, only Zydus Cadila had submitted the clinical trial protocol to the regulator to conduct trials of its vaccine candidate. </font></p><p align="justify"><font >The vaccine, said Chawdhry, would initially be made available to healthcare workers who come in direct contact with the virus and are at greater risk of being infected by it. It would could later be made available to the general public, either through government or private channels, he said.</font></p><p align="justify"><font >As on 29 December, India reported 25,572 confirmed cases of swine flu, of which 898 resulted in death. Delhi reported 8,306 cases, the highest among the states. </font></p><p align="justify"><font >According to World Health Organisation director general Margaret Chan, while the worst of the swine flu outbreak is over in the US and Canada, there is still intensive virus activity in some countries including India. Chan also warned that the virus could still mutate and countries must &ldquo;guard against complacency&rdquo;.<br /></font></p>' $lang = 'English' $SITE_URL = 'https://im4change.in/' $site_title = 'im4change' $adminprix = 'admin'</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8 Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413 Cake\View\View::_render() - CORE/src/View/View.php, line 1374 Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927 Cake\View\View::render() - CORE/src/View/View.php, line 885 Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/health-ministry-to-import-1-5-million-doses-of-h1n1-vaccine-by-radhieka-pandeya-898.html"/> <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/> <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css" media="all"/> <title>LATEST NEWS UPDATES | Health ministry to import 1.5 million doses of H1N1 vaccine by Radhieka Pandeya | Im4change.org</title> <meta name="description" content=" The health ministry has placed an order to import 1.5 million doses of the swine flu vaccine into India, which will be available in January. This is contrary to the government’s earlier claims of importing four million doses of the..."/> <script src="https://im4change.in/js/jquery-1.10.2.js"></script> <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script> <script language="javascript" type="text/javascript"> $(document).ready(function () { var img = $("img")[0]; // Get my img elem var pic_real_width, pic_real_height; $("<img/>") // Make in memory copy of image to avoid css issues .attr("src", $(img).attr("src")) .load(function () { pic_real_width = this.width; // Note: $(this).width() will not pic_real_height = this.height; // work for in memory images. }); }); </script> <style type="text/css"> @media screen { div.divFooter { display: block; } } @media print { .printbutton { display: none !important; } } </style> </head> <body> <table cellpadding="0" cellspacing="0" border="0" width="98%" align="center"> <tr> <td class="top_bg"> <div class="divFooter"> <img src="https://im4change.in/images/logo1.jpg" height="59" border="0" alt="Resource centre on India's rural distress" style="padding-top:14px;"/> </div> </td> </tr> <tr> <td id="topspace"> </td> </tr> <tr id="topspace"> <td> </td> </tr> <tr> <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> <tr> <td width="100%"> <h1 class="news_headlines" style="font-style:normal"> <strong>Health ministry to import 1.5 million doses of H1N1 vaccine by Radhieka Pandeya</strong></h1> </td> </tr> <tr> <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3"> <p align="justify"><font >The health ministry has placed an order to import 1.5 million doses of the swine flu vaccine into India, which will be available in January. </font></p><p align="justify"><font >This is contrary to the government’s earlier claims of importing four million doses of the vaccine. Indian manufacturers will now supply the remaining doses. </font></p><p align="justify"><font >“We have placed an order for importing 1.5 million doses already,” said Vineet Chawdhry, joint secretary, health ministry. “Indigenous production of the vaccine will be ready by March, so we will have that available soon as well.”</font></p><p align="justify"><font >The health ministry has been trying to make the vaccine available in India for the last two months and had sped up regulatory approvals for studies to be conducted on the safety of the vaccine. </font></p><p align="justify"><font >Chawdhry said India’s Zydus Cadila would have the vaccine ready by March, so the government would not need to import batches, which is why an order for only 1.5 million doses has been placed at the moment.</font></p><p align="justify"><font >Cadila is not one of the three Indian drug makers being supported by the government to develop and manufacture the H1N1 flu vaccine. The ones that are supported are Serum Institute of India Ltd, Bharat Biotech International Ltd and Panacea Biotech Ltd. According to ministry officials, who declined to be named, vaccines of these three firms will not be ready before April.</font></p><p align="justify"><font >Chawdhry declined to name the overseas company that will supply the vaccine, citing a confidentiality clause. Ministry officials, however, have been in talks with four international vaccine makers—GlaxoSmithKline Plc (GSK), Baxter International Inc., Novartis AG and Sanofi Pasteur SA. </font></p><p align="justify"><font >On 1 December, Mint reported that the vaccines could be available in the country by the end of the month following approvals by the Indian regulator for human clinical trials to two multinational drug makers, GSK and Baxter, while among Indian vaccine makers, only Zydus Cadila had submitted the clinical trial protocol to the regulator to conduct trials of its vaccine candidate. </font></p><p align="justify"><font >The vaccine, said Chawdhry, would initially be made available to healthcare workers who come in direct contact with the virus and are at greater risk of being infected by it. It would could later be made available to the general public, either through government or private channels, he said.</font></p><p align="justify"><font >As on 29 December, India reported 25,572 confirmed cases of swine flu, of which 898 resulted in death. Delhi reported 8,306 cases, the highest among the states. </font></p><p align="justify"><font >According to World Health Organisation director general Margaret Chan, while the worst of the swine flu outbreak is over in the US and Canada, there is still intensive virus activity in some countries including India. Chan also warned that the virus could still mutate and countries must “guard against complacency”.<br /></font></p> </font> </td> </tr> <tr> <td> </td> </tr> <tr> <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> </table></body> </html>' } $cookies = [] $values = [ (int) 0 => 'text/html; charset=UTF-8' ] $name = 'Content-Type' $first = true $value = 'text/html; charset=UTF-8'header - [internal], line ?? Cake\Http\ResponseEmitter::emitHeaders() - CORE/src/Http/ResponseEmitter.php, line 181 Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 55 Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141 [main] - ROOT/webroot/index.php, line 39
<head>
<link rel="canonical" href="<?php echo Configure::read('SITE_URL'); ?><?php echo $urlPrefix;?><?php echo $article_current->category->slug; ?>/<?php echo $article_current->seo_url; ?>.html"/>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp' $dataForView = [ 'article_current' => object(App\Model\Entity\Article) { 'id' => (int) 825, 'title' => 'Health ministry to import 1.5 million doses of H1N1 vaccine by Radhieka Pandeya', 'subheading' => '', 'description' => '<p align="justify"> <font face="arial,helvetica,sans-serif" size="3">The health ministry has placed an order to import 1.5 million doses of the swine flu vaccine into India, which will be available in January. </font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">This is contrary to the government’s earlier claims of importing four million doses of the vaccine. Indian manufacturers will now supply the remaining doses. </font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">“We have placed an order for importing 1.5 million doses already,” said Vineet Chawdhry, joint secretary, health ministry. “Indigenous production of the vaccine will be ready by March, so we will have that available soon as well.”</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">The health ministry has been trying to make the vaccine available in India for the last two months and had sped up regulatory approvals for studies to be conducted on the safety of the vaccine. </font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">Chawdhry said India’s Zydus Cadila would have the vaccine ready by March, so the government would not need to import batches, which is why an order for only 1.5 million doses has been placed at the moment.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">Cadila is not one of the three Indian drug makers being supported by the government to develop and manufacture the H1N1 flu vaccine. The ones that are supported are Serum Institute of India Ltd, Bharat Biotech International Ltd and Panacea Biotech Ltd. According to ministry officials, who declined to be named, vaccines of these three firms will not be ready before April.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">Chawdhry declined to name the overseas company that will supply the vaccine, citing a confidentiality clause. Ministry officials, however, have been in talks with four international vaccine makers—GlaxoSmithKline Plc (GSK), Baxter International Inc., Novartis AG and Sanofi Pasteur SA. </font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">On 1 December, Mint reported that the vaccines could be available in the country by the end of the month following approvals by the Indian regulator for human clinical trials to two multinational drug makers, GSK and Baxter, while among Indian vaccine makers, only Zydus Cadila had submitted the clinical trial protocol to the regulator to conduct trials of its vaccine candidate. </font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">The vaccine, said Chawdhry, would initially be made available to healthcare workers who come in direct contact with the virus and are at greater risk of being infected by it. It would could later be made available to the general public, either through government or private channels, he said.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">As on 29 December, India reported 25,572 confirmed cases of swine flu, of which 898 resulted in death. Delhi reported 8,306 cases, the highest among the states. </font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">According to World Health Organisation director general Margaret Chan, while the worst of the swine flu outbreak is over in the US and Canada, there is still intensive virus activity in some countries including India. Chan also warned that the virus could still mutate and countries must “guard against complacency”.<br /> </font> </p> ', 'credit_writer' => 'Live Mint, 30 December, 2009, http://www.livemint.com/2009/12/30204656/Health-ministry-to-import-15.html', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'health-ministry-to-import-1-5-million-doses-of-h1n1-vaccine-by-radhieka-pandeya-898', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 898, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [[maximum depth reached]], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ [maximum depth reached] ], '[dirty]' => [[maximum depth reached]], '[original]' => [[maximum depth reached]], '[virtual]' => [[maximum depth reached]], '[hasErrors]' => false, '[errors]' => [[maximum depth reached]], '[invalid]' => [[maximum depth reached]], '[repository]' => 'Articles' }, 'articleid' => (int) 825, 'metaTitle' => 'LATEST NEWS UPDATES | Health ministry to import 1.5 million doses of H1N1 vaccine by Radhieka Pandeya', 'metaKeywords' => null, 'metaDesc' => ' The health ministry has placed an order to import 1.5 million doses of the swine flu vaccine into India, which will be available in January. This is contrary to the government’s earlier claims of importing four million doses of the...', 'disp' => '<p align="justify"><font >The health ministry has placed an order to import 1.5 million doses of the swine flu vaccine into India, which will be available in January. </font></p><p align="justify"><font >This is contrary to the government’s earlier claims of importing four million doses of the vaccine. Indian manufacturers will now supply the remaining doses. </font></p><p align="justify"><font >“We have placed an order for importing 1.5 million doses already,” said Vineet Chawdhry, joint secretary, health ministry. “Indigenous production of the vaccine will be ready by March, so we will have that available soon as well.”</font></p><p align="justify"><font >The health ministry has been trying to make the vaccine available in India for the last two months and had sped up regulatory approvals for studies to be conducted on the safety of the vaccine. </font></p><p align="justify"><font >Chawdhry said India’s Zydus Cadila would have the vaccine ready by March, so the government would not need to import batches, which is why an order for only 1.5 million doses has been placed at the moment.</font></p><p align="justify"><font >Cadila is not one of the three Indian drug makers being supported by the government to develop and manufacture the H1N1 flu vaccine. The ones that are supported are Serum Institute of India Ltd, Bharat Biotech International Ltd and Panacea Biotech Ltd. According to ministry officials, who declined to be named, vaccines of these three firms will not be ready before April.</font></p><p align="justify"><font >Chawdhry declined to name the overseas company that will supply the vaccine, citing a confidentiality clause. Ministry officials, however, have been in talks with four international vaccine makers—GlaxoSmithKline Plc (GSK), Baxter International Inc., Novartis AG and Sanofi Pasteur SA. </font></p><p align="justify"><font >On 1 December, Mint reported that the vaccines could be available in the country by the end of the month following approvals by the Indian regulator for human clinical trials to two multinational drug makers, GSK and Baxter, while among Indian vaccine makers, only Zydus Cadila had submitted the clinical trial protocol to the regulator to conduct trials of its vaccine candidate. </font></p><p align="justify"><font >The vaccine, said Chawdhry, would initially be made available to healthcare workers who come in direct contact with the virus and are at greater risk of being infected by it. It would could later be made available to the general public, either through government or private channels, he said.</font></p><p align="justify"><font >As on 29 December, India reported 25,572 confirmed cases of swine flu, of which 898 resulted in death. Delhi reported 8,306 cases, the highest among the states. </font></p><p align="justify"><font >According to World Health Organisation director general Margaret Chan, while the worst of the swine flu outbreak is over in the US and Canada, there is still intensive virus activity in some countries including India. Chan also warned that the virus could still mutate and countries must “guard against complacency”.<br /></font></p>', 'lang' => 'English', 'SITE_URL' => 'https://im4change.in/', 'site_title' => 'im4change', 'adminprix' => 'admin' ] $article_current = object(App\Model\Entity\Article) { 'id' => (int) 825, 'title' => 'Health ministry to import 1.5 million doses of H1N1 vaccine by Radhieka Pandeya', 'subheading' => '', 'description' => '<p align="justify"> <font face="arial,helvetica,sans-serif" size="3">The health ministry has placed an order to import 1.5 million doses of the swine flu vaccine into India, which will be available in January. </font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">This is contrary to the government’s earlier claims of importing four million doses of the vaccine. Indian manufacturers will now supply the remaining doses. </font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">“We have placed an order for importing 1.5 million doses already,” said Vineet Chawdhry, joint secretary, health ministry. “Indigenous production of the vaccine will be ready by March, so we will have that available soon as well.”</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">The health ministry has been trying to make the vaccine available in India for the last two months and had sped up regulatory approvals for studies to be conducted on the safety of the vaccine. </font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">Chawdhry said India’s Zydus Cadila would have the vaccine ready by March, so the government would not need to import batches, which is why an order for only 1.5 million doses has been placed at the moment.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">Cadila is not one of the three Indian drug makers being supported by the government to develop and manufacture the H1N1 flu vaccine. The ones that are supported are Serum Institute of India Ltd, Bharat Biotech International Ltd and Panacea Biotech Ltd. According to ministry officials, who declined to be named, vaccines of these three firms will not be ready before April.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">Chawdhry declined to name the overseas company that will supply the vaccine, citing a confidentiality clause. Ministry officials, however, have been in talks with four international vaccine makers—GlaxoSmithKline Plc (GSK), Baxter International Inc., Novartis AG and Sanofi Pasteur SA. </font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">On 1 December, Mint reported that the vaccines could be available in the country by the end of the month following approvals by the Indian regulator for human clinical trials to two multinational drug makers, GSK and Baxter, while among Indian vaccine makers, only Zydus Cadila had submitted the clinical trial protocol to the regulator to conduct trials of its vaccine candidate. </font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">The vaccine, said Chawdhry, would initially be made available to healthcare workers who come in direct contact with the virus and are at greater risk of being infected by it. It would could later be made available to the general public, either through government or private channels, he said.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">As on 29 December, India reported 25,572 confirmed cases of swine flu, of which 898 resulted in death. Delhi reported 8,306 cases, the highest among the states. </font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">According to World Health Organisation director general Margaret Chan, while the worst of the swine flu outbreak is over in the US and Canada, there is still intensive virus activity in some countries including India. Chan also warned that the virus could still mutate and countries must “guard against complacency”.<br /> </font> </p> ', 'credit_writer' => 'Live Mint, 30 December, 2009, http://www.livemint.com/2009/12/30204656/Health-ministry-to-import-15.html', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'health-ministry-to-import-1-5-million-doses-of-h1n1-vaccine-by-radhieka-pandeya-898', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 898, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ '*' => true, 'id' => false ], '[dirty]' => [], '[original]' => [], '[virtual]' => [], '[hasErrors]' => false, '[errors]' => [], '[invalid]' => [], '[repository]' => 'Articles' } $articleid = (int) 825 $metaTitle = 'LATEST NEWS UPDATES | Health ministry to import 1.5 million doses of H1N1 vaccine by Radhieka Pandeya' $metaKeywords = null $metaDesc = ' The health ministry has placed an order to import 1.5 million doses of the swine flu vaccine into India, which will be available in January. This is contrary to the government’s earlier claims of importing four million doses of the...' $disp = '<p align="justify"><font >The health ministry has placed an order to import 1.5 million doses of the swine flu vaccine into India, which will be available in January. </font></p><p align="justify"><font >This is contrary to the government’s earlier claims of importing four million doses of the vaccine. Indian manufacturers will now supply the remaining doses. </font></p><p align="justify"><font >“We have placed an order for importing 1.5 million doses already,” said Vineet Chawdhry, joint secretary, health ministry. “Indigenous production of the vaccine will be ready by March, so we will have that available soon as well.”</font></p><p align="justify"><font >The health ministry has been trying to make the vaccine available in India for the last two months and had sped up regulatory approvals for studies to be conducted on the safety of the vaccine. </font></p><p align="justify"><font >Chawdhry said India’s Zydus Cadila would have the vaccine ready by March, so the government would not need to import batches, which is why an order for only 1.5 million doses has been placed at the moment.</font></p><p align="justify"><font >Cadila is not one of the three Indian drug makers being supported by the government to develop and manufacture the H1N1 flu vaccine. The ones that are supported are Serum Institute of India Ltd, Bharat Biotech International Ltd and Panacea Biotech Ltd. According to ministry officials, who declined to be named, vaccines of these three firms will not be ready before April.</font></p><p align="justify"><font >Chawdhry declined to name the overseas company that will supply the vaccine, citing a confidentiality clause. Ministry officials, however, have been in talks with four international vaccine makers—GlaxoSmithKline Plc (GSK), Baxter International Inc., Novartis AG and Sanofi Pasteur SA. </font></p><p align="justify"><font >On 1 December, Mint reported that the vaccines could be available in the country by the end of the month following approvals by the Indian regulator for human clinical trials to two multinational drug makers, GSK and Baxter, while among Indian vaccine makers, only Zydus Cadila had submitted the clinical trial protocol to the regulator to conduct trials of its vaccine candidate. </font></p><p align="justify"><font >The vaccine, said Chawdhry, would initially be made available to healthcare workers who come in direct contact with the virus and are at greater risk of being infected by it. It would could later be made available to the general public, either through government or private channels, he said.</font></p><p align="justify"><font >As on 29 December, India reported 25,572 confirmed cases of swine flu, of which 898 resulted in death. Delhi reported 8,306 cases, the highest among the states. </font></p><p align="justify"><font >According to World Health Organisation director general Margaret Chan, while the worst of the swine flu outbreak is over in the US and Canada, there is still intensive virus activity in some countries including India. Chan also warned that the virus could still mutate and countries must “guard against complacency”.<br /></font></p>' $lang = 'English' $SITE_URL = 'https://im4change.in/' $site_title = 'im4change' $adminprix = 'admin'
include - APP/Template/Layout/printlayout.ctp, line 8 Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413 Cake\View\View::_render() - CORE/src/View/View.php, line 1374 Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927 Cake\View\View::render() - CORE/src/View/View.php, line 885 Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
![]() |
Health ministry to import 1.5 million doses of H1N1 vaccine by Radhieka Pandeya |
The health ministry has placed an order to import 1.5 million doses of the swine flu vaccine into India, which will be available in January. This is contrary to the government’s earlier claims of importing four million doses of the vaccine. Indian manufacturers will now supply the remaining doses. “We have placed an order for importing 1.5 million doses already,” said Vineet Chawdhry, joint secretary, health ministry. “Indigenous production of the vaccine will be ready by March, so we will have that available soon as well.” The health ministry has been trying to make the vaccine available in India for the last two months and had sped up regulatory approvals for studies to be conducted on the safety of the vaccine. Chawdhry said India’s Zydus Cadila would have the vaccine ready by March, so the government would not need to import batches, which is why an order for only 1.5 million doses has been placed at the moment. Cadila is not one of the three Indian drug makers being supported by the government to develop and manufacture the H1N1 flu vaccine. The ones that are supported are Serum Institute of India Ltd, Bharat Biotech International Ltd and Panacea Biotech Ltd. According to ministry officials, who declined to be named, vaccines of these three firms will not be ready before April. Chawdhry declined to name the overseas company that will supply the vaccine, citing a confidentiality clause. Ministry officials, however, have been in talks with four international vaccine makers—GlaxoSmithKline Plc (GSK), Baxter International Inc., Novartis AG and Sanofi Pasteur SA. On 1 December, Mint reported that the vaccines could be available in the country by the end of the month following approvals by the Indian regulator for human clinical trials to two multinational drug makers, GSK and Baxter, while among Indian vaccine makers, only Zydus Cadila had submitted the clinical trial protocol to the regulator to conduct trials of its vaccine candidate. The vaccine, said Chawdhry, would initially be made available to healthcare workers who come in direct contact with the virus and are at greater risk of being infected by it. It would could later be made available to the general public, either through government or private channels, he said. As on 29 December, India reported 25,572 confirmed cases of swine flu, of which 898 resulted in death. Delhi reported 8,306 cases, the highest among the states. According to World Health Organisation director general Margaret Chan, while the worst of the swine flu outbreak is over in the US and Canada, there is still intensive virus activity in some countries including India. Chan also warned that the virus could still mutate and countries must “guard against complacency”. |